Please log in to view this page
Username
Password
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
